Perioperative medicine & outcomes
Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice
An erratum to this article was published (Anaesthesia, Oct 2024 ↗)
Authors' conclusion
There is insufficient evidence to put forward definitive guidance regarding the ideal cessation period for glucagon-like peptide-1 receptor agonists before elective surgery.
Study context
- Population
- Peri-operative patients using GLP-1 receptor agonists (type 2 DM, obesity)10 studies
- Outcome
- Risk of delayed gastric emptying and pulmonary aspiration or regurgitation in the peri-operative period
Methodological detailsMEDLINE and EMBASE searches before January 2024, narrative synthesis
- MEDLINE and EMBASE searches before January 2024
- Narrative synthesis
Main finding
As reported in the abstract
Articles located after duplicates removed
1213
Studies identified
10
Original publication
Glucagon‐like peptide‐1 receptor agonists: a narrative review of clinical pharmacology and implications for peri‐operative practice. Anaesthesia. Published 13 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →